The Problem As the pandemic seemingly becomes endemic, two new, purpose-built drugs have just been FDA-approved. Pharmaceutical companies have been busy perfecting these new treatments, paxlovid and molnupiravir, almost since the pandemic began. The approval and roll-out of vaccines similarly took the better part of a year, on an expedited process no less. But the […]
